Roche has announced that its phase 3 IMpower130 study met its co-primary endpoints of overall survival (OS) and progression-free survival (PFS) in non-small cell lung cancer (NSCLC). The combination ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

The FDA's priority review for Opdivo with AVD targets first-line treatment for stage 3 or 4 cHL in patients aged 12 and older. The phase 3 SWOG S1826 study supports the review, focusing on progression ...

The FDA has approved a combination of Pfizer’s Braftovi and Merck KGaA’s Erbitux for a form of untreated metastatic colorectal cancer, the first targeted drug regimen for this form of the disease.

Get ready, Malaysia! Plug & Play 5g advanced home WiFi with premium streaming has now arrived in your homes — just in time for festive binge-watching KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - ...

James Chen, CMT is an expert trader, investment adviser, and global market strategist. Gordon Scott has been an active investor and technical analyst or 20+ years. He is a Chartered Market Technician ...

Abstract: “Active flux” is an alternative unitary concept for the control of practically all ac drives. As aligned to rotor d-axis (for synchronous and flux-modulation machines) and to rotor flux axis ...

Abstract: With the fast development of advanced communication systems, wideband low-noise amplifiers (LNAs) have become more and more critical as they determine the overall performance of the ...

Mammotion Luba Mini AWD LiDAR: full review of the cordless robotic lawnmower for gardens up to 1500 m². Tri-Fusion LiDAR ...

Get ready, Malaysia! Plug & Play 5g advanced home WiFi with premium streaming has now arrived in your homes — just in time for festive binge-watching KUALA LUMPUR, MALAYSIA – Festive nights, ...

You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.